Highlights

[DPHARMA] YoY Quarter Result on 2017-09-30 [#3]

Stock [DPHARMA]: DUOPHARMA BIOTECH BHD
Announcement Date 17-Nov-2017
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2017
Quarter 30-Sep-2017  [#3]
Profit Trend QoQ -     18.15%    YoY -     79.86%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 133,772 142,855 125,838 115,379 80,302 79,372 44,819 19.97%
  YoY % -6.36% 13.52% 9.06% 43.68% 1.17% 77.09% -
  Horiz. % 298.47% 318.74% 280.77% 257.43% 179.17% 177.09% 100.00%
PBT 18,568 19,768 15,838 14,207 7,516 11,621 11,287 8.64%
  YoY % -6.07% 24.81% 11.48% 89.02% -35.32% 2.96% -
  Horiz. % 164.51% 175.14% 140.32% 125.87% 66.59% 102.96% 100.00%
Tax -4,441 -4,909 -3,552 -3,080 -1,290 -2,998 -2,605 9.29%
  YoY % 9.53% -38.20% -15.32% -138.76% 56.97% -15.09% -
  Horiz. % 170.48% 188.45% 136.35% 118.23% 49.52% 115.09% 100.00%
NP 14,127 14,859 12,286 11,127 6,226 8,623 8,682 8.44%
  YoY % -4.93% 20.94% 10.42% 78.72% -27.80% -0.68% -
  Horiz. % 162.72% 171.15% 141.51% 128.16% 71.71% 99.32% 100.00%
NP to SH 14,127 14,859 12,286 11,405 6,341 8,623 8,682 8.44%
  YoY % -4.93% 20.94% 7.72% 79.86% -26.46% -0.68% -
  Horiz. % 162.72% 171.15% 141.51% 131.36% 73.04% 99.32% 100.00%
Tax Rate 23.92 % 24.83 % 22.43 % 21.68 % 17.16 % 25.80 % 23.08 % 0.60%
  YoY % -3.66% 10.70% 3.46% 26.34% -33.49% 11.79% -
  Horiz. % 103.64% 107.58% 97.18% 93.93% 74.35% 111.79% 100.00%
Total Cost 119,645 127,996 113,552 104,252 74,076 70,749 36,137 22.06%
  YoY % -6.52% 12.72% 8.92% 40.74% 4.70% 95.78% -
  Horiz. % 331.09% 354.20% 314.23% 288.49% 204.99% 195.78% 100.00%
Net Worth 584,565 505,919 501,487 474,230 451,913 268,509 187,531 20.84%
  YoY % 15.55% 0.88% 5.75% 4.94% 68.30% 43.18% -
  Horiz. % 311.72% 269.78% 267.42% 252.88% 240.98% 143.18% 100.00%
Dividend
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Net Worth 584,565 505,919 501,487 474,230 451,913 268,509 187,531 20.84%
  YoY % 15.55% 0.88% 5.75% 4.94% 68.30% 43.18% -
  Horiz. % 311.72% 269.78% 267.42% 252.88% 240.98% 143.18% 100.00%
NOSH 695,911 674,559 659,852 278,959 278,959 166,776 138,912 30.78%
  YoY % 3.17% 2.23% 136.54% 0.00% 67.27% 20.06% -
  Horiz. % 500.97% 485.60% 475.01% 200.82% 200.82% 120.06% 100.00%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 10.56 % 10.40 % 9.76 % 9.64 % 7.75 % 10.86 % 19.37 % -9.61%
  YoY % 1.54% 6.56% 1.24% 24.39% -28.64% -43.93% -
  Horiz. % 54.52% 53.69% 50.39% 49.77% 40.01% 56.07% 100.00%
ROE 2.42 % 2.94 % 2.45 % 2.40 % 1.40 % 3.21 % 4.63 % -10.24%
  YoY % -17.69% 20.00% 2.08% 71.43% -56.39% -30.67% -
  Horiz. % 52.27% 63.50% 52.92% 51.84% 30.24% 69.33% 100.00%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 19.22 21.18 19.07 41.36 28.79 47.59 32.26 -8.26%
  YoY % -9.25% 11.06% -53.89% 43.66% -39.50% 47.52% -
  Horiz. % 59.58% 65.65% 59.11% 128.21% 89.24% 147.52% 100.00%
EPS 2.03 2.20 1.86 3.99 2.23 5.17 6.25 -17.08%
  YoY % -7.73% 18.28% -53.38% 78.92% -56.87% -17.28% -
  Horiz. % 32.48% 35.20% 29.76% 63.84% 35.68% 82.72% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.8400 0.7500 0.7600 1.7000 1.6200 1.6100 1.3500 -7.60%
  YoY % 12.00% -1.32% -55.29% 4.94% 0.62% 19.26% -
  Horiz. % 62.22% 55.56% 56.30% 125.93% 120.00% 119.26% 100.00%
Adjusted Per Share Value based on latest NOSH - 706,330
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 18.94 20.22 17.82 16.33 11.37 11.24 6.35 19.96%
  YoY % -6.33% 13.47% 9.12% 43.62% 1.16% 77.01% -
  Horiz. % 298.27% 318.43% 280.63% 257.17% 179.06% 177.01% 100.00%
EPS 2.00 2.10 1.74 1.61 0.90 1.22 1.23 8.43%
  YoY % -4.76% 20.69% 8.07% 78.89% -26.23% -0.81% -
  Horiz. % 162.60% 170.73% 141.46% 130.89% 73.17% 99.19% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.8276 0.7163 0.7100 0.6714 0.6398 0.3801 0.2655 20.84%
  YoY % 15.54% 0.89% 5.75% 4.94% 68.32% 43.16% -
  Horiz. % 311.71% 269.79% 267.42% 252.88% 240.98% 143.16% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 -
Price 3.1600 1.4000 1.2300 2.2000 2.0600 2.7200 3.1700 -
P/RPS 16.44 6.61 6.45 5.32 7.16 5.72 9.83 8.94%
  YoY % 148.71% 2.48% 21.24% -25.70% 25.17% -41.81% -
  Horiz. % 167.24% 67.24% 65.62% 54.12% 72.84% 58.19% 100.00%
P/EPS 155.66 63.56 66.06 53.81 90.63 52.61 50.72 20.53%
  YoY % 144.90% -3.78% 22.77% -40.63% 72.27% 3.73% -
  Horiz. % 306.90% 125.32% 130.24% 106.09% 178.69% 103.73% 100.00%
EY 0.64 1.57 1.51 1.86 1.10 1.90 1.97 -17.07%
  YoY % -59.24% 3.97% -18.82% 69.09% -42.11% -3.55% -
  Horiz. % 32.49% 79.70% 76.65% 94.42% 55.84% 96.45% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 3.76 1.87 1.62 1.29 1.27 1.69 2.35 8.14%
  YoY % 101.07% 15.43% 25.58% 1.57% -24.85% -28.09% -
  Horiz. % 160.00% 79.57% 68.94% 54.89% 54.04% 71.91% 100.00%
Price Multiplier on Announcement Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 12/11/20 29/11/19 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 -
Price 4.0400 1.3900 1.0700 2.2000 2.1000 2.7000 3.0100 -
P/RPS 21.02 6.56 5.61 5.32 7.30 5.67 9.33 14.48%
  YoY % 220.43% 16.93% 5.45% -27.12% 28.75% -39.23% -
  Horiz. % 225.29% 70.31% 60.13% 57.02% 78.24% 60.77% 100.00%
P/EPS 199.01 63.10 57.47 53.81 92.39 52.22 48.16 26.65%
  YoY % 215.39% 9.80% 6.80% -41.76% 76.92% 8.43% -
  Horiz. % 413.23% 131.02% 119.33% 111.73% 191.84% 108.43% 100.00%
EY 0.50 1.58 1.74 1.86 1.08 1.91 2.08 -21.13%
  YoY % -68.35% -9.20% -6.45% 72.22% -43.46% -8.17% -
  Horiz. % 24.04% 75.96% 83.65% 89.42% 51.92% 91.83% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 4.81 1.85 1.41 1.29 1.30 1.68 2.23 13.66%
  YoY % 160.00% 31.21% 9.30% -0.77% -22.62% -24.66% -
  Horiz. % 215.70% 82.96% 63.23% 57.85% 58.30% 75.34% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

572  344  555 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FINTEC 0.035+0.005 
 MMAG 0.185-0.005 
 VSOLAR 0.02+0.005 
 EURO 1.10-0.11 
 MTOUCHE 0.090.00 
 SERBADK 0.625-0.005 
 HHHCORP 0.190.00 
 MRDIY 3.900.00 
 FOCUS 0.04+0.005 
 EDARAN 1.17+0.265 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. What Professor Dennis Etler said about China - Koon Yew Yin Koon Yew Yin's Blog
2. Serba Dinamik rombak struktur Lembaga Pengarah, lantik IIlyas Pakeer sebagai pengerusi Oil and Gas Malaysia News
3. [MUST READ] Important message for all investors who are planning to invest in AT or existing AT shareholders Important message for all investors who are planning to invest in AT or existing AT shareholders
4. UNCOMMON ACTIVITIES SPOTTED ON RECENT CORPORATE EXERCISE OF THIS COMPANY!! Swim With Sharks
5. BREAKING: The Las Vegas Strip Is Back and May Be Better Than Ever [SEE INSIDE FOR TRIPLE DIGIT GAINS] A blog to publish and share information
6. Singapore sees first day rush for Sinovac vaccine; as 16 Covid-19 cases announced on Friday (June 18) Good Articles to Share
7. Media - Attractive valuations as recovery prospects brighten AmInvest Research Reports
8. ECO WORLD DEVELOPMENT - Proven Track Record PublicInvest Research
PARTNERS & BROKERS